Dividend
-
-
-
-
-
-
-
FDA accepts resubmitted drug application for rare pediatric disease
-
-
-
-
-
-
-
Fortress Biotech to Present at the H.C. Wainwright 27th Annual Global Investment Conference
-
-
-
-
-
-
-
Fortress Biotech Reports 2024 Financial Results and Recent Corporate Highlights
-
-
-
-
-
-
-
Fortress Biotech Announces First Patient Dosed in Phase 2 Clinical Trial of Triplex Vaccination in Stem Cell Donors to Reduce CMV Events in Recipients of HSCT
-
-
-
-
-
-
-
Fortress Biotech to Participate in October 2024 Investor Conferences
-
-
-
-
-
-
-
Fortress Biotech to Participate in the Alliance Global Partners’ (A.G.P.) Virtual Healthcare Company Showcase
-
-
-
-
-
-
-
Fortress Biotech (FBIO) Appoints Lucy Lu to its Board
-
436,668 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

